NovoCure Ltd (NASDAQ: NVCR) lost Timothy Scannell from its Board effective September 2, 2026, when his seat was vacated under the company’s Articles of Association. The retirement was not attributed to any disagreement with NovoCure or its management.
Novo Nordisk’s repurchase programme accumulated 17,275,000 B shares worth DKK 5,221,774,293, while totalBuybackssince 4 February reached 32,034,179 shares worth DKK 9,021,774,283. The purchases left 46,074,876 B shares in treasury, equal to 1.0% of share capital.Key HighlightsNovo Nordisk repurchased 32,034,179 B shares since 4 February …
Odyssey Therapeutics, Inc. (NASDAQ: ODTX) outlined a $433 million cash balance as of June 30 and said it expects the funds to support operations into H2 2028. The presentation also set out clinical milestones for its inflammatory and autoimmune disease programs.
Omada Health, Inc. (NASDAQ: OMDA) President Shao Wei-Li forfeited 1,843 shares at $22.77 per share, leaving 299,349 shares after the transaction. The transaction took place on September 5, 2026.
Opus Genetics, Inc. (NASDAQ: IRD) is moving OPGx-BEST1 into higher-dose Cohort 2 at 4.5 x 10⁹ vg/eye after low-dose Cohort 1 produced clinically meaningful visual-function improvement in all five participants. The company said the early results also showed structural changes and a favorable safety …
OS Therapies Inc (AMEX: OSTX) secured approval for its amended and restated 2023 Incentive Compensation Plan with 4,515,930 votes in favor on September 9, 2026. Its stated purpose is to attract, motivate, retain and reward high-quality personnel while creating performance incentives tied toShareholdervalue.
MERIT MEDICAL SYSTEMS INC (NASDAQ: MMSI) awarded Lewis Sheri 8,371 shares at $0 per share. Sheri is the company’s executive vice president of Global Operations.
Nanobiotix S.A. (NASDAQ: NBTX) will participate in the H.C. Wainwright Annual Global Investment Conference on September 15, 2026. The company’s management will take part in a fireside chat, giving investors a scheduled opportunity to hear directly from its senior executives.
Nano-X Imaging Ltd. (NASDAQ: NNOX) reported an additional U.S. distribution agreement and a Costa Rica distribution agreement supporting continued expansion across Latin America while holding $31.023 million in cash at June 30, 2026. The balance stood at $49.151 million on December 31, 2025. The …
National Vision Holdings, Inc. (NASDAQ: EYE) Chief Technology Officer David Cutler exercised options covering 12,998 shares on Sep. 8, 2026. The transaction left him with 12,998 shares, representing about 100.0% of his resulting share holding.